Iron, microbiota and colorectal cancer

Area of Science:

• Oncology
• Microbiology
• Gastroenterology

Background:

• Iron deficiency and anemia are prevalent in colorectal cancer (CRC) patients.
• While iron replacement is standard care, excess iron is implicated in CRC promotion.
• Gut microbiota dysbiosis is increasingly recognized as a factor in CRC development.

Purpose of the Study:

• To explore the potential role of iron in colorectal carcinogenesis via gut microbiota modulation.
• To understand how iron supplementation might influence the gut microbiome in CRC patients.

Main Methods:

• Review of mechanistic and population studies on iron, gut microbiota, and CRC.
• Analysis of the proposed mechanisms linking iron, bacterial shifts, and inflammation.

Main Results:

• Iron is a critical nutrient for bacteria; excess iron may favor pathogenic bacterial growth.
• A shift towards pathogenic bacteria can increase toxic metabolites, promoting inflammation and CRC.
• This highlights a potential mechanism for iron's dual role in CRC.

Conclusions:

• Iron's impact on gut microbiota may explain its association with colorectal carcinogenesis.
• Careful consideration of iron's role is needed when managing anemia in CRC patients.
• Further research into iron-microbiota interactions is crucial for CRC prevention and treatment.